ondasdechoque.org
PT-BR

Rotator-cuff / subacromial pain: mixed or unspecified subtype · Single-group study · 2026

Does shoulder tendon pain improve after focused shockwave plus exercise and rehab?

In this study of 239 people, shoulder pain dropped from 6.5 to about 4 out of 10 four months after three sessions of focused shockwave, one a week, alongside home exercises and supervised rehab. Shoulder function scores rose by about 15 points. People with a higher body mass index tended to gain less function.

Improved over time
adults with shoulder tendon pain
239
sessions, one a week
3
months of follow-up
4

Good to know: Everyone also did daily home exercises and 16 weeks of supervised rehab; there was no comparison group. Followed for 4 months.

Nusca SM, Latini E, Santilli G, et al. Medical Sciences (Basel, Switzerland), 2026 · Read the paper ↗

How this study worked

StartFollow-up239 people
One group was followed over time, without a comparison group. Each dot stands for 3 people.

What happened

Shoulder pain

0–10 pain scale · start and after four months

StartAfter 4 months

Pain dropped from 6.5 to about 4 out of 10 after four months. Shoulder function scores rose from about 60 to about 76 out of 100.
Show the numbers
GroupPeopleStartAfter 4 months
Shockwave + exercise and rehab2396.53.96

The treatment

Shockwave + exercise and rehab

Focused, once a week for 3 weeks

Focused wavesMeet at a focal zone below the skin
Sessions
3, one a week
Pulses
2,400 per session
Strength
0.15mJ/mm² · 4 per second
Numbing
None
Device
Modulith SLK
Everyone also got
Daily home exercises plus supervised rehabilitation three times a week for 16 weeks

Compared with: No comparison group

Settings are what each study used, not a prescription.

Who took part

Adults with long-lasting supraspinatus (rotator-cuff) tendon pain, with or without calcium deposits, confirmed on imaging. Of 312 people screened, 239 were analysed; 41 had incomplete follow-up.

Side effects

No serious side effects. Some people had brief local discomfort, and everyone analysed completed all three sessions.

All the numbers and the full appraisal
FROM THE FULL PAPER

The results, in numbers.

Adults with chronic, imaging-confirmed supraspinatus tendinopathy (calcific and noncalcific), treated with focused ESWT; final cohort 239 of 312 screened; 73 were excluded, including 41 (13.1%) with incomplete follow-up.

Focused ESWT plus home exercise and supervised rehabilitation239analyzed

Retrospective single-arm cohort with no untreated or active comparator. Of 312 patients screened, 73 were excluded (41 with incomplete follow-up, 18 rotator cuff tears, 8 recent injections, 6 other reasons), leaving 239 analysed; the paper prints no separate enrolled count. The printed loss to follow-up of 13.1% is 41 of the 312 screened.

10-point VAS; higher=worse1 reported outcome
01
Baseline to 4 months

Shoulder pain (VAS)

10-point VAS; higher=worse points

means
GroupnBaselineFollow-up
Focused ESWT plus home exercise and supervised rehabilitation2396.5 (SD 1.35)3.96 (SD 2.09)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

MD2.55CI 95% 2.29 to 2.81

Within-cohort change, baseline to month 4

239 participants in this estimate

-0.3Equal results 03.1
REPORTED COMPARISON TESTp <0.001

Baseline versus 4-month follow-up

Within-cohort pre/post comparison

Pain decreased by a mean 2.55 points (95% CI 2.29–2.81) at 4 months; within-cohort p<0.001.

Analysis details and source

Uncontrolled pre/post estimate in a retrospective cohort receiving concurrent home exercise and a 16-week supervised rehabilitation program; the change cannot be attributed to ESWT alone. The Methods describe a 100 mm VAS (0–100 mm), but Table 2 labels it 0–10 and reports values in that range; values are kept as printed.

Constant–Murley 0–100; higher=better1 reported outcome
02
Baseline to 4 months

Shoulder function (Constant–Murley)

Constant–Murley 0–100; higher=better points

means
GroupnBaselineFollow-up
Focused ESWT plus home exercise and supervised rehabilitation23960.38 (SD 14.53)75.88 (SD 15.52)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

MD15.5CI 95% 13.67 to 17.34

Within-cohort change, baseline to month 4

239 participants in this estimate

-2.1Equal results 019.4
REPORTED COMPARISON TESTp <0.001

Baseline versus 4-month follow-up

Within-cohort pre/post comparison

Mean function score increased 15.50 points (95% CI 13.67–17.34) by month 4; p<0.001.

Analysis details and source

Uncontrolled pre/post estimate in a retrospective cohort receiving concurrent home exercise and a 16-week supervised rehabilitation program; the change cannot be attributed to ESWT alone.

Multivariable linear regression for Delta VAS and Delta Constant–Murley1 reported outcome
03
Four-month response

Predictors of four-month treatment response

Multivariable linear regression for Delta VAS and Delta Constant–Murley Unstandardized regression coefficient β

Higher baseline VAS predicted larger absolute pain reduction (β=0.571, 95% CI 0.37–0.77; p<0.001). Higher baseline Constant–Murley also predicted pain reduction (β=0.025; 0.01–0.04; p=0.010). For functional change, higher baseline Constant–Murley (β=−0.504; −0.63 to −0.38) and higher BMI (β=−0.949 per kg/m²; −1.43 to −0.47), both p<0.001, predicted smaller improvement. Models explained adjusted R²=0.122 for VAS and 0.275 for function.

Analysis details and source

Exploratory backward stepwise models in one retrospective cohort; predictors require external validation. Diabetes, hypercholesterolemia and hypertension were not retained as independent predictors.

Four-category ordinal patient-rated outcome; success defined by the source as score 1–21 reported outcome
04
Baseline and 4-month follow-up

Roles and Maudsley Score distribution

Four-category ordinal patient-rated outcome; success defined by the source as score 1–2 participants (%)

In this uncontrolled cohort (N=239), baseline to month 4 counts were: excellent 39 (16.3%) to 147 (61.5%); good 114 (47.7%) to 71 (29.7%); acceptable 75 (31.4%) to 20 (8.4%); poor 11 (4.6%) to 1 (0.4%). The source-defined success category (score 1–2) was 153 (64.0%) at baseline and 218 (91.2%) at month 4. These are within-cohort descriptive changes; the table reports no comparative p value.

Analysis details and source

Do not interpret this uncontrolled pre/post distribution as causal ESWT efficacy or as a between-group effect. The paper defines the score as a patient-rated treatment outcome (1 = no pain, full movement and activity), yet Table 2 gives a baseline distribution with 39 patients (16.3%) rated excellent, although all had shoulder pain for at least 3 months; counts are kept as printed.

How treatment was delivered
Focused ESWT

Modulith SLK electromagnetic generator with integrated inline ultrasound guidance, targeting supraspinatus insertion at greater tuberosity; no local anesthesia. EFD 0.15 mJ/mm², 2,400 pulses/session, 4 Hz, three treatments at weekly intervals. All received daily home pendulum exercises, passive and active-assisted range of motion, and progressive rotator cuff strengthening; no other physical modalities allowed.

Supervised rehabilitation program (all patients)

Started with the first f-ESWT session and continued for 16 weeks: three sessions per week of about 45–60 min, supervised by a physical therapist specialized in shoulder rehabilitation (warm-up; progressive rotator cuff and scapular strengthening; posterior capsule and pectoralis minor stretching), progressed by tolerance with pain monitoring; adherence tracked by direct supervision and attendance records.

HARMS & TOLERABILITY

No serious adverse events related to focused ESWT were observed. Some patients reported transient local discomfort that did not require discontinuation; all 239 analyzed participants completed three sessions.

LIMITS OF THE ANALYSIS

Retrospective single-center cohort with no comparator, concurrent daily home exercise and a 16-week supervised rehabilitation program, and 41 of 312 screened patients lost to follow-up (13.1%). Follow-up was four months. Backward stepwise models may be unstable and are hypothesis-generating; no external validation. Improvement cannot be assigned to ESWT alone.

Findings checked against the full source by a separate automated reviewer.

Limitations noted by the reviewers

  • Retrospective single-center cohort with no comparator, concurrent daily home exercise and a 16-week supervised rehabilitation program, and 41 of 312 screened patients lost to follow-up (13.1%). Follow-up was four months. Backward stepwise models may be unstable and are hypothesis-generating; no external validation. Improvement cannot be assigned to ESWT alone.
Research review

Source-linked critical reading

Retrospective treated-cohort prognostic study

Reading depthMaterial consulted
Technical source record

Read full article, all raw tables/captions, cohort attrition, ESWT and exercise protocol, 4-month outcomes, regression models, safety and limitations.

Review statusAI-assisted draft · independent automated checkThis automated check comes before the editor’s clinical review.
Design and evidence base

Single-center retrospective cohort, consecutive patients treated June 2020–December 2025; 239 analyzed after 73 exclusions, 41 of them for incomplete follow-up.

Participants

Adults with chronic imaging-confirmed calcific or noncalcific supraspinatus tendinopathy, symptoms ≥3 months; full-thickness tears and recent injection/nerve block were excluded.

Intervention

Three ultrasound-guided focused sessions at weekly intervals using Modulith SLK, EFD 0.15 mJ/mm², 2,400 pulses/session, 4 Hz, no local anesthesia. All received daily home exercise and 16 weeks of supervised rehabilitation three times a week; other modalities prohibited.

Comparator

No untreated, exercise-only or alternative-treatment comparator.

Outcomes

At four months, VAS fell 2.55 points (95% CI 2.29–2.81); Constant–Murley rose 15.50 (13.67–17.34); both p<0.001. Models associated baseline severity and BMI with change. The Roles and Maudsley ordinal distribution is also reported at baseline and month 4: excellent 39/239 (16.3%) to 147/239 (61.5%), good 114 (47.7%) to 71 (29.7%), acceptable 75 (31.4%) to 20 (8.4%), and poor 11 (4.6%) to 1 (0.4%). Source-defined success (scores 1–2) was 153/239 (64.0%) to 218/239 (91.2%). This is uncontrolled cohort description; no comparative p value is supplied.

Comparative findings

Higher BMI predicted smaller Constant–Murley improvement (β −0.949 per kg/m², 95% CI −1.43 to −0.47). Baseline scores predicted absolute change. Models explained 12.2% and 27.5% adjusted variance.

Harms

No serious ESWT adverse event; transient local discomfort occurred. All analyzed patients completed three sessions.

Limitations

Retrospective, uncontrolled, single-center, four-month follow-up, 41 of 312 screened (13.1%) lost, concurrent exercise and stepwise model instability; prediction models not externally validated.

Applicability

This cohort describes short-term outcomes after combined ESWT and exercise, not the independent treatment effect of ESWT.

Research needs

Prospective external validation and controlled studies should assess prognostic variables and separate ESWT from exercise effects.

THE ORIGINAL SOURCE

Read the original article.

Clinical and Metabolic Predictors of Response to Focused Extracorporeal Shockwave Therapy in Rotator Cuff Tendinopathy: A Retrospective Cohort Study.

Nusca SM, Latini E, Santilli G, Beccarini G, Bova V, Santoboni F, Santilli V, Felzani G, Perroni F, Vulpiani M, Sisti D, Vetrano M. · Medical sciences (Basel, Switzerland) · 2026

Open the publication record or available full-text files.

Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →